Preimplantation Genetic Testing for Monogenic Disorders
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Preimplantation genetic testing (PGT) has evolved into a well-established alternative to invasive prenatal diagnosis, even though genetic testing of single or few cells is quite challenging. PGT-M is in theory available for any monogenic disorder for which the disease-causing locus has been unequivocally identified. In practice, the list of indications for which PGT is allowed may vary substantially from country to country, depending on PGT regulation. Technically, the switch from multiplex PCR to robust generic workflows with whole genome amplification followed by SNP array or NGS represents a major improvement of the last decade: the waiting time for the couples has been substantially reduced since the customized preclinical workup can be omitted and the workload for the laboratories has decreased. Another evolution is that the generic methods now allow for concurrent analysis of PGT-M and PGT-A. As innovative algorithms are being developed and the cost of sequencing continues to decline, the field of PGT moves forward to a sequencing-based, all-in-one solution for PGT-M, PGT-SR, and PGT-A. This will generate a vast amount of complex genetic data entailing new challenges for genetic counseling. In this review, we summarize the state-of-the-art for PGT-M and reflect on its future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unlike a monogenic (Mendelian) disease, AMD heritability is not controlled by a single mutation that can be identified from a pedigree analysis and observed in a family line [18,19].”
From Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians. (2024) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · cited 1×
“These loci are nuclear (X-linked, autosomal, dominantly or recessively inherited) or mitochondrial (maternally inherited) and involve (likely) pathogenic genetic variant(s) (class 4–5) [17].”
BackgroundPregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification
Handyside, A. H., Kontogianni, E. H., Hardy, K., & Winston, R. M. L. (1990) · Nature · doi:10.1038/344768a0 · Cited by 1,604
The International Glossary on Infertility and Fertility Care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.005 · Cited by 1,505
The international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320 · cited 15×
“These protocols often provide a tandem solution, combining PGT-A with PGT-M, and can be classified in two groups, depending on whether sequencing data for the monogenic locus are derived with a targeted or a genome-wide method.”
BackgroundInfluentialGenome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell
Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012) · Science · doi:10.1126/science.1229164 · Cited by 1,154 · cited 1×
“Both the Rubicon PicoPLEX and the MALBAC (Multiple Annealing and Looping Based Amplification Cycles) protocol initiate with DNA fragmentation and a pre-amplification MDA reaction using hybrid primers, followed by PCR [43,44].”
MethodReproductive Technologies and the Risk of Birth Defects
Davies, M. J., Moore, V. M., Willson, K. J., Van Essen, P., Priest, K., Scott, H., Haan, E. A., & Chan, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1008095 · Cited by 809 · cited 1×
“Studies showed that IVF and ICSI are associated with a small but statistically significant increase in congenital anomalies at birth, compared with the general population [60,61].”
BackgroundPandey, S., Shetty, A., Hamilton, M., Bhattacharya, S., & Maheshwari, A. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms018 · Cited by 786 · cited 1×
“Studies showed that IVF and ICSI are associated with a small but statistically significant increase in congenital anomalies at birth, compared with the general population [60,61].”
BackgroundDe Rycke, M., Belva, F., Goossens, V., Moutou, C., SenGupta, S. B., Traeger-Synodinos, J., & Coonen, E. (2015) · Human Reproduction · doi:10.1093/humrep/dev122 · Cited by 703
Scott, R. T., Upham, K. M., Forman, E. J., Zhao, T., & Treff, N. R. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.039 · Cited by 574 · cited 1×
“A paired clinical trial showed that implantation rates of 50% in the nonbiopsied group were diminished to 30% in the cleavage-stage biopsy group, while similar implantation rates were obtained for the blastocyst-biopsy group versus the nonbiopsied group [29].”
ResultLaFramboise, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp552 · Cited by 467
Handyside, A. H., Harton, G. L., Mariani, B., Thornhill, A. R., Affara, N., Shaw, M.-A., & Griffin, D. K. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.069971 · Cited by 399 · cited 1×
“Handyside and coworkers developed karyomapping, a family-based computational phasing approach for reconstruction of SNP haplotypes which flank the pathogenic variant(s) [5,50].”
BackgroundLoutradi, K. E., Kolibianakis, E. M., Venetis, C. A., Papanikolaou, E. G., Pados, G., Bontis, I., & Tarlatzis, B. C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.010 · Cited by 390 · cited 1×
“Vitrification has been shown to be superior to slow-freezing in terms of survival rate for both cleavage-stage embryos and blastocysts [37].”
BackgroundA Quantitative Comparison of Single-Cell Whole Genome Amplification Methods
de Bourcy, C. F. A., De Vlaminck, I., Kanbar, J. N., Wang, J., Gawad, C., & Quake, S. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105585 · Cited by 307
Whole-genome multiple displacement amplification from single cells
Spits, C., Le Caignec, C., De Rycke, M., Van Haute, L., Van Steirteghem, A., Liebaers, I., & Sermon, K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.326 · Cited by 282 · cited 1×
“Because of the proofreading activity of the Phi29 polymerase, the error rate of MDA-based WGA is much lower compared with Taq DNA polymerase-based methods, but the non-linear amplification yields over- or under-representation of genomic regions [42].”
ResultSurvey on ART and IUI: legislation, regulation, funding and registries in European countries
Calhaz-Jorge, C., De Geyter, C. H., Kupka, M. S., Wyns, C., Mocanu, E., Motrenko, T., Scaravelli, G., Smeenk, J., Vidakovic, S., & Goossens, V (2020) · Human Reproduction Open · doi:10.1093/hropen/hoz044 · Cited by 262 · cited 2×
“A recent overview of regulatory frameworks in 43 European countries shows only two countries where PGT is not allowed (Malta and Bosnia & Herzegovina) [15].”
BackgroundUbaldi, F. M., Capalbo, A., Vaiarelli, A., Cimadomo, D., Colamaria, S., Alviggi, C., Trabucco, E., Venturella, R., Vajta, G., & Rienzi, L. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.03.002 · Cited by 234
De Vos, A., Staessen, C., De Rycke, M., Verpoest, W., Haentjens, P., Devroey, P., Liebaers, I., & Van de Velde, H. (2009) · Human Reproduction · doi:10.1093/humrep/dep251 · Cited by 223 · cited 1×
“It was shown that a two-cell removal at the cleavage stage harms embryonic development and implantation potential more than the removal of one cell [26].”
BackgroundART in Europe, 2015: results generated from European registries by ESHRE†
De Geyter, C., Calhaz-Jorge, C., Kupka, M. S., Wyns, C., Mocanu, E., Motrenko, T., Scaravelli, G., Smeenk, J., Vidakovic, S., Goossens, V, et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoz038 · Cited by 213 · cited 1×
“0% per frozen embryo transfer, over all PGT indications [58].”
BackgroundNatesan, S. A., Bladon, A. J., Coskun, S., Qubbaj, W., Prates, R., Munne, S., Coonen, E., Dreesen, J. C. F. M., Stevens, S. J. C., Paulussen, A. D. C., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.45 · Cited by 191 · cited 1×
“Handyside and coworkers developed karyomapping, a family-based computational phasing approach for reconstruction of SNP haplotypes which flank the pathogenic variant(s) [5,50].”
BackgroundESHRE PGT Consortium good practice recommendations for the organisation of PGT†
ESHRE PGT Consortium Steering Committee, Carvalho, F., Coonen, E., Goossens, V., Kokkali, G., Rubio, C., Meijer-Hoogeveen, M., Moutou, C., Vermeulen, N., & De Rycke, M. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa021 · Cited by 180 · cited 1×
“Transport PGT is a service that has expanded substantially, despite the challenges related to transport and collaborations over (long) distances [9].”
BackgroundNon-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics?
Leaver, M., & Wells, D. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmz033 · Cited by 179 · cited 1×
“Future research should also focus on the origin of the cell-free DNA to determine whether collected samples reflect the real genetic status of the embryo [36].”
BackgroundTreff, N. R., Fedick, A., Tao, X., Devkota, B., Taylor, D., & Scott, R. T. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.12.018 · Cited by 169 · cited 1×
“In one report, the pathogenic variant loci were captured in a preamplification reaction with pathogenic variant specific primers while the concurrent inclusion of a specially designed primer pool allowed for parallel aneuploidy screening via real-time quantitative PCR [4].”
ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders†
ESHRE PGT-M Working Group, Carvalho, F., Moutou, C., Dimitriadou, E., Dreesen, J. C. F. M., Giménez, C., Goossens, V., Kakourou, G., Vermeulen, N., Zuccarello, D., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa018 · Cited by 167 · cited 1×
“Genetic implication counseling is a necessary part of the procedure [11].”
BackgroundThe Future of Cryopreservation in Assisted Reproductive Technologies
Bosch, E., Vos, M. D., & Humaidan, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00067 · Cited by 167
Concurrent Whole-Genome Haplotyping and Copy-Number Profiling of Single Cells
Esteki, M. Z., Dimitriadou, E., Mateiu, L. M., Melotte, C., der Aa, N. V., Kumar, P., Das, R., Theunis, K., Cheng, J., Legius, E., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.011 · Cited by 152 · cited 1×
“For instance, haplarithmisis is a computational pipeline that primarily relies on continuous BAFs and allows haplotype and copy number detection as well as determination of the parental origin of the chromosomal anomaly [6].”
MethodYin, X., Tan, K., Vajta, G., Jiang, H., Tan, Y., Zhang, C., Chen, F., Chen, S., Zhang, C., Pan, X., et al. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.106211 · Cited by 152
Yan, L., Huang, L., Xu, L., Huang, J., Ma, F., Zhu, X., Tang, Y., Liu, M., Lian, Y., Liu, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523297113 · Cited by 146 · cited 1×
“1–2×), yielding targeted SNP haplotyping results for PGT-M together with genome-wide PGT-A data [55].”
BackgroundRycke, M. D., Goossens, V., Kokkali, G., Meijer-Hoogeveen, M., Coonen, E., & Moutou, C. (2017) · Human Reproduction · doi:10.1093/humrep/dex265 · Cited by 143 · cited 2×
“The co-amplification of STR markers with or without the pathogenic variant amplicon(s) at the level of a single or few cells yields a more accurate test and this so-called haplotyping approach has been the gold-standard for over two decades [27,40].”
BackgroundMethodKokkali, G., Coticchio, G., Bronet, F., Célébi, C., Cimadomo, D., Goossens, V., Liss, J., Nunes, S. G., Sfontouris, I. A., Vermeulen, N., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa020 · Cited by 140
Corrigendum. ART in Europe, 2015: results generated from European registries by ESHRE
Geyter, C. D., Calhaz–Jorge, C., Kupka, M. S., Wyns, C., Mocanu, E. V., Motrenko, T., Scaravelli, G., Smeenk, J. M. J., Vidakovic, S., & Goossens, V. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa038 · Cited by 137
Taskforce 5: preimplantation genetic diagnosis
Shenfield, F. (2003) · Human Reproduction · doi:10.1093/humrep/deg110 · Cited by 131 · cited 1×
“The alternative with direct testing and non-disclosure of the results is not recommended as it obligates extreme confidentiality and may impose unethical behavior on the practitioners (for instance, fake embryo transfers) [20].”
BackgroundESHRE PGT-SR/PGT-A Working Group, Coonen, E., Rubio, C., Christopikou, D., Dimitriadou, E., Gontar, J., Goossens, V., Maurer, M., Spinella, F., Vermeulen, N., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa017 · Cited by 117
Capalbo, A., Romanelli, V., Patassini, C., Poli, M., Girardi, L. D. C., Giancani, A., Stoppa, M., Cimadomo, D., Ubaldi, F. M., & Rienzi, L. F. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.031 · Cited by 106 · cited 2×
“Several studies showed that the karyotype concordance between blastocoel fluid samples and inner cell mass and/or TE cells varied widely, indicating that genetic analysis following blastocentesis is insufficiently accurate for clinical PGT-A/PGT-SR [35].”
BackgroundResultBayefsky, M. J. (2016) · Reproductive Biomedicine & Society Online · doi:10.1016/j.rbms.2017.01.001 · Cited by 100 · cited 1×
“The USA, for example, has no established restrictions on PGT practice and as such, PGT is also used for nonmedical reasons such as social sexing [14].”
BackgroundAccuracy of Preimplantation Diagnosis of Single-Gene Disorders by Polar Body Analysis of Oocytes
Rechitsky, S., STROM, C. M., Verlinsky, O., Amet, T., Ivakhnenko, V., Kukharenko, V. I., Kuliev, A., & Verlinsky, Y. (1999) · Journal of Assisted Reproduction and Genetics · doi:10.1023/a:1020312823155 · Cited by 90 · cited 1×
“From these earliest approaches, contamination and allele drop out (ADO) surfaced as important issues that could lead to misdiagnosis [39].”
BackgroundNeonatal follow-up of 995 consecutively born children after embryo biopsy for PGD
Desmyttere, S., Rycke, M. D., Staessen, C., Liebaers, I., Schrijver, F. D., Verpoest, W., Haentjens, P., & Bonduelle, M. (2011) · Human Reproduction · doi:10.1093/humrep/der360 · Cited by 90 · cited 1×
“condition of newborn children nor did it change the risk for major malformations [63].”
BackgroundKubicek, D., Horňák, M., Horak, J., Navratil, R., Tauwinklova, G., Rubeš, J., & Veselá, K. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.11.023 · Cited by 87 · cited 1×
“As such, SNP arrays can reveal the presence of aneuploidies, polyploidies, and uniparental disomy [53].”
BackgroundGinoza, M., & Isasi, R. M. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036681 · Cited by 82
Renwick, P., Trussler, J., Lashwood, A., Braude, P., & Ogilvie, C. M. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.01.006 · Cited by 81 · cited 1×
“WGA followed by standard PCR reactions of a multitude of STR markers flanking the region(s) of interest is simpler and requires a shorter validation, compared to single or few cell multiplex PCR [48].”
MethodLangmore, J. P. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.4.557 · Cited by 80
Whole genome amplification from a single cell: a new era for preimplantation genetic diagnosis
Coşkun, S., & Alsmadi, O. A. (2007) · Prenatal Diagnosis · doi:10.1002/pd.1667 · Cited by 74 · cited 2×
“The use of Taq DNA polymerase yielded an average fragment length of 400–500 bp (with a maximum size of 3 kb) and introduced many DNA sequence errors [41].”
BackgroundMethodMagli, M. C., Albanese, C., Crippa, A., Tabanelli, C., Ferraretti, A. P., & Gianaroli, L. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.016 · Cited by 72 · cited 1×
“Another option is blastocentesis, which is the aspiration of blastocoel fluid (BF) containing cell-free DNA (cfDNA) from the blastocoel cavity with a fine needle [32].”
BackgroundCimadomo, D., Rienzi, L. F., Capalbo, A., Rubio, C., Innocenti, F., García-Pascual, C. M., Ubaldi, F. M., & Handyside, A. H. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa019 · Cited by 72 · cited 1×
“TE biopsy provides more cells (ideally five to eight cells) for genetic analysis providing a better accuracy [28].”
BackgroundBrouillet, S., Martinez, G., Coutton, C., & Hamamah, S. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.02.002 · Cited by 71 · cited 2×
“A true non-invasive alternative is to rely on cfDNA present in the spent blastocyst medium (SBM) [34].”
BackgroundInfluentialSmeets, H. J. M., Sallevelt, S. C. E. H., Dreesen, J. C. F. M., de Die-Smulders, C. E. M., & de Coo, I. F. M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12866 · Cited by 70 · cited 1×
“It is an ethically difficult indication group as the approach reduces the risk for an affected child rather than eliminating it and this requires case-by-case counseling [21].”
BackgroundPreimplantation genetic diagnosis: a national multicenter obstetric and neonatal follow-up study
Bay, B., Ingerslev, H. J., Lemmen, J. G., Degn, B., Rasmussen, I. A., & Kesmodel, U. S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1092 · Cited by 66 · cited 1×
“These results were in line with studies carried out in other centers using embryo biopsy at cleavage stage [64,65].”
ResultHe, H., Jing, S., Lu, C. F., Tan, Y. Q., Luo, K. L., Zhang, S. P., Gong, F., Lu, G. X., & Lin, G. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.03.006 · Cited by 66
Masset, H., Esteki, M. Z., Dimitriadou, E., Dreesen, J. C. F. M., Debrock, S., Derhaag, J. G., Derks, K., Destouni, A., Drüsedau, M., Meekels, J., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dez106 · Cited by 64 · cited 15×
“These protocols often provide a tandem solution, combining PGT-A with PGT-M, and can be classified in two groups, depending on whether sequencing data for the monogenic locus are derived with a targeted or a genome-wide method.”
MethodInfluentialon behalf of the BruMaStra PGD working group, van Rij, M. C., Rademaeker, M. D., Moutou, C., Dreesen, J. C. F. M., Rycke, M. D., Liebaers, I., Geraedts, J. P. M., de Die-Smulders, C. E. M., & Viville, S. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.202 · Cited by 63 · cited 1×
“In families with a history of late-onset neurodegenerative disorders such as Huntington’s disease, individuals at risk who want to avoid pre-symptomatic testing but wish for their own biological unaffected children may opt for PGT with exclusion testing [19].”
BackgroundVan Landuyt, L., Polyzos, N. P., De Munck, N., Blockeel, C., Van de Velde, H., & Verheyen, G. (2015) · Human Reproduction · doi:10.1093/humrep/dev218 · Cited by 62 · cited 1×
“This procedure is considered less invasive than TE biopsy and results in embryo collapse which is a manipulation applied in routine vitrification practice to maximize embryo survival post-vitrification [33].”
MethodReproductive Technologies and the Risk of Birth Defects
Davies, M. J., Moore, V., Willson, K. J., ESSEN, P. V., Priest, K., Scott, H. M., Haan, E., & Chan, A. C. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000421443.42267.9d · Cited by 61
Backenroth, D., Zahdeh, F., Kling, Y., Peretz, A., Rosen, T., Kort, D., Zeligson, S., Dror, T., Kirshberg, S., Burak, E., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0351-7 · Cited by 55
Deleye, L., Coninck, D. I. M. D., Christodoulou, C. I., Sante, T., Dheedene, A., Heindryckx, B., den Abbeel, E. V., Sutter, P. D., Menten, B., Deforce, D. L. D., et al. (2015) · Scientific Reports · doi:10.1038/srep11711 · Cited by 50
Chow, J. F. C., Cheng, H. H. Y., Lau, E. Y. L., Yeung, W. S. B., & Ng, E. H. Y. (2020) · Genomics · doi:10.1016/j.ygeno.2019.04.001 · Cited by 49 · cited 1×
“High-resolution characterization of breakpoints located outside highly repetitive regions is now achievable with long-read nanopore sequencing [52].”
BackgroundLaurie, A. D., Hill, A. M., Harraway, J. R., FELLOWES, A. P., PHILLIPSON, G. T., Benny, P. S., Smith, M. P., & George, P. M. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03768.x · Cited by 49 · cited 1×
“Single cell biopsy at day 3 followed by multiplex PCR became the method of choice for the detection of monogenic disorders [3].”
MethodPreimplantation genetic diagnosis for Marfan syndrome
Spits, C., Rycke, M. D., Verpoest, W., Lissens, W., Steirteghem, A. V., Liebaers, I., & Sermon, K. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.059 · Cited by 42
Chamayou, S., Sicali, M., Alecci, C., Ragolia, C., Liprino, A., Nibali, D., Storaci, G., Cardea, A., & Guglielmino, A. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0868-0 · Cited by 42
Biopsy of Human Morula-Stage Embryos: Outcome of 215 IVF/ICSI Cycles with PGS
Zakharova, E. E., Zaletova, V., & Krivokharchenko, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106433 · Cited by 40 · cited 1×
“An alternative method is morula-stage biopsy, performed on day 4, after artificial decompaction using Ca/Mg-free medium [30].”
MethodWinter, C., Acker, F. V., Bonduelle, M., Desmyttere, S., Schrijver, F. D., & Nekkebroeck, J. (2014) · Human Reproduction · doi:10.1093/humrep/deu165 · Cited by 33
Zhu, J., Zhu, Q., Wang, Y., Wang, B., Lyu, Q., & Kuang, Y. (2018) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2018.1554012 · Cited by 30 · cited 10×
“The recent retrospective study in which a cohort of 1,721 children born after PGT with blastocyst biopsy and cryopreservation was compared with an IVF/ICSI control group showed no significant difference in neonatal outcome, indicating that neither embryo biopsy at blastocyst stage nor cryopreservation added further ri…”
BackgroundInfluentialSingle‐cell sequencing and mini‐sequencing for preimplantation genetic diagnosis
García-Bermúdez, M., Piyamongkol, W., Tomaz, S., Dudman, E., Sherlock, J. K., & Wells, D. (2003) · Prenatal Diagnosis · doi:10.1002/pd.658 · Cited by 28
Preimplantation genetic testing with HLA matching: from counseling to birth and beyond
Rycke, M. D., Vos, A. D., Belva, F., Berckmoes, V., Bonduelle, M., Buysse, A., Keymolen, K., Liebaers, I., Nekkebroeck, J., Verdyck, P., et al. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0732-z · Cited by 28 · cited 1×
“This is particularly true for indications with limited success rate a priori, such as for PGT-M with HLA typing where the chance of finding a genetically compatible embryo was shown to be only 16% [59].”
BackgroundSelf-citationBerckmoes, V., Verdyck, P., Becker, P. D., Vos, A. D., Verheyen, G., der Niepen, P. V., Verpoest, W., Liebaers, I., Bonduelle, M., Keymolen, K., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dez027 · Cited by 28 · cited 1×
“A recent study showed that fertilization rates and live birth delivery rates tended to be lower for couples with the male partner affected with ADPKD, compared to couples with the female partner affected with ADPKD, although the higher female age in the former group was a confounding factor [22].”
BackgroundSelf-citationThe clinical utility of PGD with HLA matching: a collaborative multi-centre ESHRE study
Kakourou, G., Kahraman, S., Ekmekci, G. C., Tac, H. A., Kourlaba, G., Kourkouni, Ε., Sanz, A. C. C., Martin, J. L., Malmgren, H., Giménez-Rodríguez, C., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex384 · Cited by 26 · cited 1×
“HLA typing alone is carried out for couples having a child with an acquired hematological malignancy, but mostly, HLA typing is combined with PGT for a monogenic disorder, commonly immunodeficiencies and hemoglobinopathies [18].”
MethodPerinatal follow-up of children born after preimplantation genetic diagnosis between 1995 and 2014
Heijligers, M., van Montfoort, A. P. A., Meijer-Hoogeveen, M., Broekmans, F. J., Bouman, K., Homminga, I., Dreesen, J. C. F. M., Paulussen, A. D. C., Engelen, J. J. M., Coonen, E., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1286-2 · Cited by 26 · cited 1×
“These results were in line with studies carried out in other centers using embryo biopsy at cleavage stage [64,65].”
ResultHeijligers, M., Peeters, A., van Montfoort, A. P. A., Nijsten, J., Janssen, E. J. M., Gunnewiek, F. K., de Rooy, R., van Golde, R. J. T., Coonen, E., Meijer-Hoogeveen, M., et al. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.01.035 · Cited by 26
Refining the ethics of preimplantation genetic diagnosis: a plea for contextualized proportionality
Dondorp, W., & de Wert, G. (2019) · Bioethics · doi:10.1111/bioe.12534 · Cited by 26 · cited 1×
“It is clear that this should be balanced with thorough discussions and ethical reflections [16].”
BackgroundWinter, C., Acker, F. V., Bonduelle, M., Desmyttere, S., & Nekkebroeck, J. (2015) · Human Reproduction · doi:10.1093/humrep/dev036 · Cited by 25
Chamayou, S., Sicali, M., Lombardo, D., Alecci, C., Ragolia, C., Maglia, E., Liprino, A., Cardea, C., Storaci, G., Romano, S., et al. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01635-2 · Cited by 24
Irani, M., Zaninović, N., Canon, C. M., O’Neill, C. L., Gunnala, V., Zhan, Q., Palermo, G. D., Reichman, D., & Rosenwaks, Z. (2018) · Human Reproduction · doi:10.1093/humrep/dey053 · Cited by 23 · cited 1×
“Of note were findings of lower implantation and live birth rates as well as higher rates of complex aneuploidy [31].”
BackgroundSacks, G. C., Altarescu, G., Guedalia, J. S. B., Varshaver, I., Gilboa, T., Levy‐Lahad, E., & Eldar‐Geva, T. (2015) · Child Neuropsychology · doi:10.1080/09297049.2015.1014900 · Cited by 18
Deleye, L., Gansemans, Y., Coninck, D. I. M. D., Nieuwerburgh, F. V., & Deforce, D. L. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196334 · Cited by 14
Novel Double Factor PGT strategy analyzing blastocyst stage embryos in a single NGS procedure
del Rey, J., Vidal, F., Ramírez, L., Borràs, N., Corrales, I., Iris Garcia-martinez, A., Martinez-Pasarell, O., Fernández, S. F., Garcia-Cruz, R., Pujol, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205692 · Cited by 14 · cited 1×
“, PGT-M and PGT-A together in a single workflow [57].”
BackgroundBelva, F., Roelants, M., Kluijfhout, S. A., Winter, C., Schrijver, F. D., Desmyttere, S., Rycke, M. D., Tournaye, H. J., Liebaers, I., & Bonduelle, M. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy013 · Cited by 11 · cited 1×
“Another study on body composition and blood pressure showed no adverse outcomes for 6-year-old children born after PGT (with day 3 embryo biopsy followed by blastocyst transfer) compared to children born after ICSI without embryo biopsy [71].”
Hu, X., Ding, C., Zhang, D., Zhou, W., Wang, J., Zeng, Y., Lv, J., Xu, Y., & Zhou, C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1347778 · Cited by 4
Cited by
(2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.003 · Cited by 57
Volozonoka, L., Miskova, A., & Gailite, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094819 · Cited by 52
“Hence, MPS-based approaches are regarded as the most powerful platforms for future PGT [89].”
MethodPreimplantation Genetic Testing for Genetic Diseases: Limits and Review of Current Literature
Giuliano, R., Maione, A., Vallefuoco, A., Sorrentino, U., & Zuccarello, D. (2023) · Genes · doi:10.3390/genes14112095 · Cited by 65
“Preimplantation genetic testing for structural rearrangements (PGT-SR) has emerged as a promising technology in the field of reproductive medicine, allowing couples with chromosomal rearrangements to reduce the risk of transmitting genetic abnormalities to their offspring [11].”
BackgroundAnalysis of rare thalassemia genetic variants based on third-generation sequencing
Peng, C., Zhang, H., Ren, J., Chen, H., Du, Z., Zhao, T., Mao, A., Xu, R., Lu, Y., Wang, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14038-8 · Cited by 46
Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants
Vuković, P., Peccatori, F. A., Massarotti, C., Miralles, M. S., Beketić-Orešković, L., & Lambertini, M. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103201 · Cited by 43
Metadata
- Authors
- De Rycke, M., & Berckmoes, V.
- Affiliations
- Center for Medical Genetics, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
- Universitair Ziekenhuis Brussel (BE)
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2020-07-31
- Volume
- 11
- Issue
- 8
- Pages
- 871
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC7463885
- OpenAlex
- W3022322625
- Cited by
- 140
- References
- 75
- Citations by year
- 2026: 15 · 2025: 24 · 2024: 35 · 2023: 35 · 2022: 20 · 2021: 8 · 2020: 3
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- preimplantation genetic testing, monogenic disorders, preimplantation genetic testing for monogenic disorders, preimplantation genetic testing for aneuploidy, preimplantation genetic testing for structural rearrangements, whole genome amplification, SNP array, next-generation sequencing, genetic counseling
- MeSH terms
- Genetic Testing, Humans, Sequence Analysis, DNA, Preimplantation Diagnosis, Reproductive Techniques, Assisted, Genetic Diseases, Inborn
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.